This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 13 from Patent US 20020137896
General Information
DCTPep ID DCTPep01214
Peptide Name Sequence 13 from Patent US 20020137896
Sequence ADPRVVVDLRFFGKSDIVEENRVTFGPNPK
Sequence Length 30
UniProt ID Q8J2V8
PubChem CID Not available
Origin Synthetic construct
Type Native peptide
Classification
ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep01214
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C153H241N43O45
Absent amino acids CHMQWY
Theoretical pI 6.29
Acidic residues 5
Basic residues 5
Polar residues 6
Molecular weight (Average) 3402.86
Molecular weight (Monoisotopic) 3400.79
Common amino acids V
Net charge 0
Instability index (II) 11.26
Aliphatic index 77.67
Grand average of hydropathicity (GRAVY) -0.447
Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2002/0137896 A1
Patent Title Antitumor protein and gene encoding same.
Other Iinformation Granted Patent Family: 3s / 5ex; Family Jurisdictions: US; Legal Status: Expired; Application No: 91196901; Filed:Jul 24, 2001; Published: Sep 26, 2002; Earliest Priority: Feb 13, 1997; Granted: Jul 13, 2004
This work is licensed under a Creative Commons Attribution 4.0 International License.